A Major Cochrane Review Casts Doubt on the Efficacy and Safety of Amyloid-Targeting Alzheimer’s Drugs
A comprehensive analysis of 17 clinical trials involving over 20,000 participants has concluded that drugs designed to target amyloid beta proteins in the brain are unlikely to offer significant clinical…


The Hidden Environmental Cost of the Puffer Jacket: Unpacking the Footprint of a Cold-Weather Staple





